Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf J Dirschinger

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Heart Journal. Case Reports|April 26, 2019
Diagnosis of a rare cardiac human herpesvirus-8 positive B-cell lymphoma manifestation: a case report of a transoesophageal echocardiography-guided trans-septal catheter biopsyChristine M Schneider, Alessandra Buiatti, Kristina Schwamborn, et al.
Pediatric Cardiology|March 14, 2012
Recapitulating long-QT syndrome using induced pluripotent stem cell technologyRalf J Dirschinger, Alexander Goedel, Alessandra Moretti, et al.
Journal of Visualized Experiments : Jove|May 7, 2014
Cell labeling and injection in developing embryonic mouse heartsEmilye Hiriart, Patrick van Vliet, Ralf J Dirschinger, et al.
Journal of Cardiovascular Translational Research|October 19, 2012
Modeling long-QT syndromes with iPS cellsDaniel Sinnecker, Alexander Goedel, Tatjana Dorn, et al.
Reviews of Physiology, Biochemistry and Pharmacology|March 27, 2012
Induced pluripotent stem cells in cardiovascular researchDaniel Sinnecker, Ralf J Dirschinger, Alexander Goedel, et al.
Phlebology|July 18, 2015
Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstructionNicolas Langwieser, Isabell Bernlochner, Isabel Wustrow, et al.
Frontiers in Physiology|February 3, 2025
Post-extrasystolic variation of ST segment and T wave as a mortality risk predictor after myocardial infarctionRalf J Dirschinger, Alexander Müller, Petra Barthel, et al.
Frontiers in Physiology|February 4, 2020
Risk Prediction After Myocardial Infarction by Cyclic Variation of Heart Rate, a Surrogate of Sleep-Disordered Breathing Assessed From Holter ECGsXu Cao, Alexander Müller, Ralf J Dirschinger, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 25, 2018
Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammationKarl P Kunze, Ralf J Dirschinger, Hans Kossmann, et al.
Blood|October 31, 2002
The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3Karsten Spiekermann, Ralf J Dirschinger, Ruth Schwab, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Heart Journal. Case Reports|April 26, 2019
Diagnosis of a rare cardiac human herpesvirus-8 positive B-cell lymphoma manifestation: a case report of a transoesophageal echocardiography-guided trans-septal catheter biopsyChristine M Schneider, Alessandra Buiatti, Kristina Schwamborn, et al.
Pediatric Cardiology|March 14, 2012
Recapitulating long-QT syndrome using induced pluripotent stem cell technologyRalf J Dirschinger, Alexander Goedel, Alessandra Moretti, et al.
Journal of Visualized Experiments : Jove|May 7, 2014
Cell labeling and injection in developing embryonic mouse heartsEmilye Hiriart, Patrick van Vliet, Ralf J Dirschinger, et al.
Journal of Cardiovascular Translational Research|October 19, 2012
Modeling long-QT syndromes with iPS cellsDaniel Sinnecker, Alexander Goedel, Tatjana Dorn, et al.
Reviews of Physiology, Biochemistry and Pharmacology|March 27, 2012
Induced pluripotent stem cells in cardiovascular researchDaniel Sinnecker, Ralf J Dirschinger, Alexander Goedel, et al.
Phlebology|July 18, 2015
Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstructionNicolas Langwieser, Isabell Bernlochner, Isabel Wustrow, et al.
Frontiers in Physiology|February 3, 2025
Post-extrasystolic variation of ST segment and T wave as a mortality risk predictor after myocardial infarctionRalf J Dirschinger, Alexander Müller, Petra Barthel, et al.
Frontiers in Physiology|February 4, 2020
Risk Prediction After Myocardial Infarction by Cyclic Variation of Heart Rate, a Surrogate of Sleep-Disordered Breathing Assessed From Holter ECGsXu Cao, Alexander Müller, Ralf J Dirschinger, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 25, 2018
Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammationKarl P Kunze, Ralf J Dirschinger, Hans Kossmann, et al.
Blood|October 31, 2002
The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3Karsten Spiekermann, Ralf J Dirschinger, Ruth Schwab, et al.
Pageof 2